nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—STK11—obesity	0.205	0.426	CbGaD
Sunitinib—RPS6KB1—obesity	0.151	0.314	CbGaD
Sunitinib—TYK2—obesity	0.125	0.26	CbGaD
Sunitinib—CYP3A7—Cimetidine—obesity	0.00913	0.181	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Cimetidine—obesity	0.00913	0.181	CbGbCtD
Sunitinib—CYP3A5—Cimetidine—obesity	0.00685	0.136	CbGbCtD
Sunitinib—CYP3A4—Sibutramine—obesity	0.00564	0.112	CbGbCtD
Sunitinib—ABCB1—Cimetidine—obesity	0.00446	0.0882	CbGbCtD
Sunitinib—CYP3A4—Benzphetamine—obesity	0.00428	0.0847	CbGbCtD
Sunitinib—CYP3A4—Bupropion—obesity	0.00364	0.072	CbGbCtD
Sunitinib—CYP3A4—Orlistat—obesity	0.00297	0.0587	CbGbCtD
Sunitinib—CYP3A4—Cimetidine—obesity	0.00267	0.0529	CbGbCtD
Sunitinib—CYP3A4—Topiramate—obesity	0.00175	0.0346	CbGbCtD
Sunitinib—PRPF4—Promazine—Benzphetamine—obesity	0.00079	1	CbGdCrCtD
Sunitinib—Procainamide—SLC22A1—obesity	0.000488	0.377	CrCbGaD
Sunitinib—Metoclopramide—DRD2—obesity	0.000443	0.342	CrCbGaD
Sunitinib—Procainamide—BCHE—obesity	0.000362	0.28	CrCbGaD
Sunitinib—Haemoglobin—Bupropion—obesity	0.000136	0.00101	CcSEcCtD
Sunitinib—Headache—Diethylpropion—obesity	0.000135	0.00101	CcSEcCtD
Sunitinib—Haemorrhage—Bupropion—obesity	0.000135	0.001	CcSEcCtD
Sunitinib—Hepatitis—Bupropion—obesity	0.000135	0.001	CcSEcCtD
Sunitinib—Malnutrition—Sibutramine—obesity	0.000135	0.001	CcSEcCtD
Sunitinib—Back pain—Orlistat—obesity	0.000135	0.001	CcSEcCtD
Sunitinib—Hypoaesthesia—Bupropion—obesity	0.000134	0.000997	CcSEcCtD
Sunitinib—LRRK2—adrenal gland—obesity	0.000134	0.00102	CbGeAlD
Sunitinib—YES1—adrenal cortex—obesity	0.000134	0.00102	CbGeAlD
Sunitinib—Muscle spasms—Orlistat—obesity	0.000134	0.000994	CcSEcCtD
Sunitinib—TYK2—pituitary gland—obesity	0.000134	0.00102	CbGeAlD
Sunitinib—Urinary tract disorder—Bupropion—obesity	0.000133	0.000989	CcSEcCtD
Sunitinib—TYK2—adipose tissue—obesity	0.000133	0.00101	CbGeAlD
Sunitinib—Oedema peripheral—Bupropion—obesity	0.000133	0.000987	CcSEcCtD
Sunitinib—Hot flush—Topiramate—obesity	0.000133	0.000986	CcSEcCtD
Sunitinib—Flatulence—Sibutramine—obesity	0.000133	0.000986	CcSEcCtD
Sunitinib—Connective tissue disorder—Bupropion—obesity	0.000133	0.000984	CcSEcCtD
Sunitinib—STK16—liver—obesity	0.000132	0.00101	CbGeAlD
Sunitinib—MAP3K3—cardiovascular system—obesity	0.000132	0.00101	CbGeAlD
Sunitinib—Urethral disorder—Bupropion—obesity	0.000132	0.000982	CcSEcCtD
Sunitinib—TAOK3—adrenal cortex—obesity	0.000132	0.00101	CbGeAlD
Sunitinib—PRKAA1—adrenal gland—obesity	0.000132	0.00101	CbGeAlD
Sunitinib—Dysgeusia—Sibutramine—obesity	0.000132	0.000979	CcSEcCtD
Sunitinib—HIPK3—liver—obesity	0.000132	0.001	CbGeAlD
Sunitinib—HIPK2—liver—obesity	0.000132	0.001	CbGeAlD
Sunitinib—Menopausal symptoms—Topiramate—obesity	0.000132	0.000978	CcSEcCtD
Sunitinib—DYRK1A—endocrine gland—obesity	0.000131	0.001	CbGeAlD
Sunitinib—IRAK1—adipose tissue—obesity	0.000131	0.001	CbGeAlD
Sunitinib—Vomiting—Cimetidine—obesity	0.000131	0.000971	CcSEcCtD
Sunitinib—PTK2B—adrenal gland—obesity	0.00013	0.000995	CbGeAlD
Sunitinib—RIOK2—liver—obesity	0.00013	0.000994	CbGeAlD
Sunitinib—TNK1—liver—obesity	0.00013	0.000994	CbGeAlD
Sunitinib—Back pain—Sibutramine—obesity	0.00013	0.000967	CcSEcCtD
Sunitinib—FLT4—adrenal gland—obesity	0.00013	0.000993	CbGeAlD
Sunitinib—Rash—Cimetidine—obesity	0.00013	0.000963	CcSEcCtD
Sunitinib—ULK3—digestive system—obesity	0.00013	0.000989	CbGeAlD
Sunitinib—MAP2K2—digestive system—obesity	0.00013	0.000989	CbGeAlD
Sunitinib—Dermatitis—Cimetidine—obesity	0.00013	0.000962	CcSEcCtD
Sunitinib—Muscle spasms—Sibutramine—obesity	0.000129	0.000962	CcSEcCtD
Sunitinib—PDGFRB—islet of Langerhans—obesity	0.000129	0.000987	CbGeAlD
Sunitinib—RPS6KB1—pituitary gland—obesity	0.000129	0.000987	CbGeAlD
Sunitinib—Headache—Cimetidine—obesity	0.000129	0.000957	CcSEcCtD
Sunitinib—RPS6KB1—adipose tissue—obesity	0.000129	0.000983	CbGeAlD
Sunitinib—RET—pituitary gland—obesity	0.000129	0.000981	CbGeAlD
Sunitinib—FGR—pituitary gland—obesity	0.000129	0.000981	CbGeAlD
Sunitinib—Nausea—Diethylpropion—obesity	0.000128	0.000954	CcSEcCtD
Sunitinib—MERTK—endocrine gland—obesity	0.000128	0.000979	CbGeAlD
Sunitinib—CSNK1E—adrenal gland—obesity	0.000128	0.000979	CbGeAlD
Sunitinib—FGFR1—adrenal gland—obesity	0.000128	0.000979	CbGeAlD
Sunitinib—AXL—pituitary gland—obesity	0.000128	0.000977	CbGeAlD
Sunitinib—FGR—adipose tissue—obesity	0.000128	0.000977	CbGeAlD
Sunitinib—FLT1—cardiovascular system—obesity	0.000128	0.000976	CbGeAlD
Sunitinib—Erythema multiforme—Bupropion—obesity	0.000127	0.000947	CcSEcCtD
Sunitinib—AXL—adipose tissue—obesity	0.000127	0.000973	CbGeAlD
Sunitinib—Hypoglycaemia—Topiramate—obesity	0.000127	0.000945	CcSEcCtD
Sunitinib—Angioedema—Orlistat—obesity	0.000127	0.000944	CcSEcCtD
Sunitinib—DAPK3—liver—obesity	0.000126	0.000965	CbGeAlD
Sunitinib—IRAK4—adrenal gland—obesity	0.000126	0.000964	CbGeAlD
Sunitinib—Eye disorder—Bupropion—obesity	0.000126	0.000936	CcSEcCtD
Sunitinib—TBK1—digestive system—obesity	0.000126	0.000962	CbGeAlD
Sunitinib—MAP4K4—endocrine gland—obesity	0.000126	0.000961	CbGeAlD
Sunitinib—CLK2—liver—obesity	0.000125	0.000956	CbGeAlD
Sunitinib—TYK2—digestive system—obesity	0.000125	0.000955	CbGeAlD
Sunitinib—Cardiac disorder—Bupropion—obesity	0.000125	0.00093	CcSEcCtD
Sunitinib—Flushing—Bupropion—obesity	0.000125	0.00093	CcSEcCtD
Sunitinib—KIT—respiratory system—obesity	0.000125	0.000954	CbGeAlD
Sunitinib—MAP4K2—liver—obesity	0.000125	0.000952	CbGeAlD
Sunitinib—Hyponatraemia—Topiramate—obesity	0.000125	0.000926	CcSEcCtD
Sunitinib—Anaemia—Sibutramine—obesity	0.000124	0.000924	CcSEcCtD
Sunitinib—Pain in extremity—Topiramate—obesity	0.000124	0.000922	CcSEcCtD
Sunitinib—FLT3—endocrine gland—obesity	0.000124	0.000948	CbGeAlD
Sunitinib—MAP3K12—endocrine gland—obesity	0.000124	0.000948	CbGeAlD
Sunitinib—ULK3—adrenal gland—obesity	0.000123	0.000943	CbGeAlD
Sunitinib—MAP2K2—adrenal gland—obesity	0.000123	0.000943	CbGeAlD
Sunitinib—SLK—pituitary gland—obesity	0.000123	0.00094	CbGeAlD
Sunitinib—STK3—liver—obesity	0.000123	0.000939	CbGeAlD
Sunitinib—Angioedema—Sibutramine—obesity	0.000123	0.000914	CcSEcCtD
Sunitinib—SLK—adipose tissue—obesity	0.000123	0.000937	CbGeAlD
Sunitinib—MAP3K2—adrenal gland—obesity	0.000123	0.000936	CbGeAlD
Sunitinib—RPS6KA3—endocrine gland—obesity	0.000122	0.000935	CbGeAlD
Sunitinib—Angiopathy—Bupropion—obesity	0.000122	0.000909	CcSEcCtD
Sunitinib—Nausea—Cimetidine—obesity	0.000122	0.000907	CcSEcCtD
Sunitinib—PDGFRB—respiratory system—obesity	0.000122	0.000932	CbGeAlD
Sunitinib—Immune system disorder—Bupropion—obesity	0.000122	0.000905	CcSEcCtD
Sunitinib—MAP2K1—endocrine gland—obesity	0.000122	0.000928	CbGeAlD
Sunitinib—FGFR2—adipose tissue—obesity	0.000122	0.000928	CbGeAlD
Sunitinib—Mediastinal disorder—Bupropion—obesity	0.000122	0.000903	CcSEcCtD
Sunitinib—JAK2—pituitary gland—obesity	0.000121	0.000927	CbGeAlD
Sunitinib—MAP3K7—adrenal gland—obesity	0.000121	0.000927	CbGeAlD
Sunitinib—ROCK1—liver—obesity	0.000121	0.000927	CbGeAlD
Sunitinib—Cough—Orlistat—obesity	0.000121	0.000902	CcSEcCtD
Sunitinib—RPS6KB1—digestive system—obesity	0.000121	0.000925	CbGeAlD
Sunitinib—STK10—cardiovascular system—obesity	0.000121	0.000924	CbGeAlD
Sunitinib—Chills—Bupropion—obesity	0.000121	0.000899	CcSEcCtD
Sunitinib—JAK2—adipose tissue—obesity	0.000121	0.000923	CbGeAlD
Sunitinib—TAOK3—cardiovascular system—obesity	0.000121	0.00092	CbGeAlD
Sunitinib—Convulsion—Orlistat—obesity	0.000121	0.000895	CcSEcCtD
Sunitinib—Leukopenia—Sibutramine—obesity	0.000121	0.000895	CcSEcCtD
Sunitinib—RET—digestive system—obesity	0.00012	0.00092	CbGeAlD
Sunitinib—FGR—digestive system—obesity	0.00012	0.00092	CbGeAlD
Sunitinib—Arrhythmia—Bupropion—obesity	0.00012	0.000895	CcSEcCtD
Sunitinib—TBK1—adrenal gland—obesity	0.00012	0.000916	CbGeAlD
Sunitinib—CSNK1A1—endocrine gland—obesity	0.00012	0.000916	CbGeAlD
Sunitinib—Face oedema—Topiramate—obesity	0.00012	0.000891	CcSEcCtD
Sunitinib—FYN—pituitary gland—obesity	0.00012	0.000914	CbGeAlD
Sunitinib—PDGFRA—cardiovascular system—obesity	0.00012	0.000914	CbGeAlD
Sunitinib—FYN—adipose tissue—obesity	0.000119	0.000911	CbGeAlD
Sunitinib—CLK1—endocrine gland—obesity	0.000119	0.00091	CbGeAlD
Sunitinib—TYK2—adrenal gland—obesity	0.000119	0.00091	CbGeAlD
Sunitinib—Alopecia—Bupropion—obesity	0.000119	0.000885	CcSEcCtD
Sunitinib—Myalgia—Orlistat—obesity	0.000118	0.00088	CcSEcCtD
Sunitinib—Chest pain—Orlistat—obesity	0.000118	0.00088	CcSEcCtD
Sunitinib—DYRK1A—liver—obesity	0.000118	0.000904	CbGeAlD
Sunitinib—KDR—adrenal cortex—obesity	0.000118	0.000904	CbGeAlD
Sunitinib—MAP2K5—adrenal cortex—obesity	0.000118	0.000904	CbGeAlD
Sunitinib—Mental disorder—Bupropion—obesity	0.000118	0.000878	CcSEcCtD
Sunitinib—IRAK1—adrenal gland—obesity	0.000118	0.000898	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000118	0.000874	CcSEcCtD
Sunitinib—Cough—Sibutramine—obesity	0.000117	0.000873	CcSEcCtD
Sunitinib—Malnutrition—Bupropion—obesity	0.000117	0.000872	CcSEcCtD
Sunitinib—CAMK2G—endocrine gland—obesity	0.000117	0.000894	CbGeAlD
Sunitinib—BMP2K—endocrine gland—obesity	0.000117	0.000894	CbGeAlD
Sunitinib—MAP4K5—pituitary gland—obesity	0.000117	0.000894	CbGeAlD
Sunitinib—MAP3K3—pituitary gland—obesity	0.000117	0.000894	CbGeAlD
Sunitinib—Convulsion—Sibutramine—obesity	0.000117	0.000867	CcSEcCtD
Sunitinib—MAP4K5—adipose tissue—obesity	0.000117	0.00089	CbGeAlD
Sunitinib—MAP3K3—adipose tissue—obesity	0.000117	0.00089	CbGeAlD
Sunitinib—Blood creatinine increased—Topiramate—obesity	0.000116	0.000864	CcSEcCtD
Sunitinib—Hypertension—Sibutramine—obesity	0.000116	0.000863	CcSEcCtD
Sunitinib—LRRK2—endocrine gland—obesity	0.000116	0.000886	CbGeAlD
Sunitinib—Dry mouth—Orlistat—obesity	0.000116	0.00086	CcSEcCtD
Sunitinib—MERTK—liver—obesity	0.000116	0.000883	CbGeAlD
Sunitinib—Flatulence—Bupropion—obesity	0.000116	0.000859	CcSEcCtD
Sunitinib—CSF1R—adrenal cortex—obesity	0.000116	0.000882	CbGeAlD
Sunitinib—RPS6KB1—adrenal gland—obesity	0.000116	0.000882	CbGeAlD
Sunitinib—Dehydration—Topiramate—obesity	0.000115	0.000858	CcSEcCtD
Sunitinib—Dysgeusia—Bupropion—obesity	0.000115	0.000854	CcSEcCtD
Sunitinib—RET—adrenal gland—obesity	0.000115	0.000876	CbGeAlD
Sunitinib—FGR—adrenal gland—obesity	0.000115	0.000876	CbGeAlD
Sunitinib—Liver function test abnormal—Topiramate—obesity	0.000115	0.000852	CcSEcCtD
Sunitinib—Arthralgia—Sibutramine—obesity	0.000115	0.000851	CcSEcCtD
Sunitinib—Myalgia—Sibutramine—obesity	0.000115	0.000851	CcSEcCtD
Sunitinib—Chest pain—Sibutramine—obesity	0.000115	0.000851	CcSEcCtD
Sunitinib—FGFR2—digestive system—obesity	0.000114	0.000874	CbGeAlD
Sunitinib—PRKAA1—endocrine gland—obesity	0.000114	0.000873	CbGeAlD
Sunitinib—AXL—adrenal gland—obesity	0.000114	0.000873	CbGeAlD
Sunitinib—JAK2—digestive system—obesity	0.000114	0.000869	CbGeAlD
Sunitinib—MAP4K4—liver—obesity	0.000114	0.000867	CbGeAlD
Sunitinib—Oedema—Orlistat—obesity	0.000114	0.000843	CcSEcCtD
Sunitinib—Back pain—Bupropion—obesity	0.000114	0.000843	CcSEcCtD
Sunitinib—Abdominal pain upper—Topiramate—obesity	0.000113	0.000842	CcSEcCtD
Sunitinib—FLT1—pituitary gland—obesity	0.000113	0.000864	CbGeAlD
Sunitinib—PTK2B—endocrine gland—obesity	0.000113	0.000863	CbGeAlD
Sunitinib—Hypokalaemia—Topiramate—obesity	0.000113	0.000839	CcSEcCtD
Sunitinib—Muscle spasms—Bupropion—obesity	0.000113	0.000838	CcSEcCtD
Sunitinib—Infection—Orlistat—obesity	0.000113	0.000838	CcSEcCtD
Sunitinib—FLT4—endocrine gland—obesity	0.000113	0.000861	CbGeAlD
Sunitinib—NUAK2—liver—obesity	0.000113	0.00086	CbGeAlD
Sunitinib—FLT1—adipose tissue—obesity	0.000113	0.00086	CbGeAlD
Sunitinib—FYN—digestive system—obesity	0.000112	0.000857	CbGeAlD
Sunitinib—Dry mouth—Sibutramine—obesity	0.000112	0.000833	CcSEcCtD
Sunitinib—FLT3—liver—obesity	0.000112	0.000854	CbGeAlD
Sunitinib—MAP3K12—liver—obesity	0.000112	0.000854	CbGeAlD
Sunitinib—EPHB6—pituitary gland—obesity	0.000112	0.000854	CbGeAlD
Sunitinib—Toxic epidermal necrolysis—Topiramate—obesity	0.000112	0.000831	CcSEcCtD
Sunitinib—Aspartate aminotransferase increased—Topiramate—obesity	0.000112	0.000831	CcSEcCtD
Sunitinib—EPHB6—adipose tissue—obesity	0.000111	0.00085	CbGeAlD
Sunitinib—Nervous system disorder—Orlistat—obesity	0.000111	0.000827	CcSEcCtD
Sunitinib—CSNK1E—endocrine gland—obesity	0.000111	0.000849	CbGeAlD
Sunitinib—Nasopharyngitis—Topiramate—obesity	0.000111	0.000825	CcSEcCtD
Sunitinib—RPS6KA3—liver—obesity	0.00011	0.000843	CbGeAlD
Sunitinib—Skin disorder—Orlistat—obesity	0.00011	0.000819	CcSEcCtD
Sunitinib—SLK—adrenal gland—obesity	0.00011	0.00084	CbGeAlD
Sunitinib—Oedema—Sibutramine—obesity	0.00011	0.000816	CcSEcCtD
Sunitinib—MAP2K1—liver—obesity	0.00011	0.000837	CbGeAlD
Sunitinib—Alanine aminotransferase increased—Topiramate—obesity	0.00011	0.000814	CcSEcCtD
Sunitinib—Muscular weakness—Topiramate—obesity	0.00011	0.000814	CcSEcCtD
Sunitinib—Infection—Sibutramine—obesity	0.000109	0.000811	CcSEcCtD
Sunitinib—FGFR2—adrenal gland—obesity	0.000109	0.000833	CbGeAlD
Sunitinib—JAK2—adrenal gland—obesity	0.000109	0.000828	CbGeAlD
Sunitinib—Anaemia—Bupropion—obesity	0.000108	0.000806	CcSEcCtD
Sunitinib—CSNK1A1—liver—obesity	0.000108	0.000826	CbGeAlD
Sunitinib—YES1—pituitary gland—obesity	0.000108	0.000825	CbGeAlD
Sunitinib—Shock—Sibutramine—obesity	0.000108	0.000803	CcSEcCtD
Sunitinib—MAP2K5—cardiovascular system—obesity	0.000108	0.000825	CbGeAlD
Sunitinib—KDR—cardiovascular system—obesity	0.000108	0.000825	CbGeAlD
Sunitinib—Abdominal distension—Topiramate—obesity	0.000108	0.000803	CcSEcCtD
Sunitinib—YES1—adipose tissue—obesity	0.000108	0.000822	CbGeAlD
Sunitinib—Thrombocytopenia—Sibutramine—obesity	0.000108	0.000799	CcSEcCtD
Sunitinib—CLK1—liver—obesity	0.000108	0.000821	CbGeAlD
Sunitinib—Dysphagia—Topiramate—obesity	0.000107	0.000797	CcSEcCtD
Sunitinib—Angioedema—Bupropion—obesity	0.000107	0.000797	CcSEcCtD
Sunitinib—ULK3—endocrine gland—obesity	0.000107	0.000817	CbGeAlD
Sunitinib—MAP2K2—endocrine gland—obesity	0.000107	0.000817	CbGeAlD
Sunitinib—FYN—adrenal gland—obesity	0.000107	0.000817	CbGeAlD
Sunitinib—Skin disorder—Sibutramine—obesity	0.000107	0.000793	CcSEcCtD
Sunitinib—TAOK3—pituitary gland—obesity	0.000107	0.000815	CbGeAlD
Sunitinib—STK10—adipose tissue—obesity	0.000107	0.000814	CbGeAlD
Sunitinib—MAP3K2—endocrine gland—obesity	0.000106	0.000811	CbGeAlD
Sunitinib—TAOK3—adipose tissue—obesity	0.000106	0.000811	CbGeAlD
Sunitinib—FLT1—digestive system—obesity	0.000106	0.00081	CbGeAlD
Sunitinib—PDGFRA—adipose tissue—obesity	0.000106	0.000806	CbGeAlD
Sunitinib—CAMK2G—liver—obesity	0.000106	0.000806	CbGeAlD
Sunitinib—BMP2K—liver—obesity	0.000106	0.000806	CbGeAlD
Sunitinib—CSF1R—cardiovascular system—obesity	0.000105	0.000805	CbGeAlD
Sunitinib—Pancreatitis—Topiramate—obesity	0.000105	0.000782	CcSEcCtD
Sunitinib—Leukopenia—Bupropion—obesity	0.000105	0.00078	CcSEcCtD
Sunitinib—Anorexia—Sibutramine—obesity	0.000105	0.000778	CcSEcCtD
Sunitinib—LRRK2—liver—obesity	0.000105	0.000799	CbGeAlD
Sunitinib—MAP4K5—adrenal gland—obesity	0.000105	0.000798	CbGeAlD
Sunitinib—MAP3K3—adrenal gland—obesity	0.000105	0.000798	CbGeAlD
Sunitinib—TBK1—endocrine gland—obesity	0.000104	0.000795	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Orlistat—obesity	0.000103	0.000768	CcSEcCtD
Sunitinib—TYK2—endocrine gland—obesity	0.000103	0.000789	CbGeAlD
Sunitinib—Bronchitis—Topiramate—obesity	0.000103	0.000767	CcSEcCtD
Sunitinib—PRKAA1—liver—obesity	0.000103	0.000787	CbGeAlD
Sunitinib—Abdominal discomfort—Topiramate—obesity	0.000103	0.000764	CcSEcCtD
Sunitinib—Insomnia—Orlistat—obesity	0.000103	0.000763	CcSEcCtD
Sunitinib—PDGFRB—adrenal cortex—obesity	0.000102	0.000782	CbGeAlD
Sunitinib—Cough—Bupropion—obesity	0.000102	0.000761	CcSEcCtD
Sunitinib—Paraesthesia—Orlistat—obesity	0.000102	0.000757	CcSEcCtD
Sunitinib—PTK2B—liver—obesity	0.000102	0.000778	CbGeAlD
Sunitinib—Pancytopenia—Topiramate—obesity	0.000102	0.000757	CcSEcCtD
Sunitinib—Convulsion—Bupropion—obesity	0.000102	0.000755	CcSEcCtD
Sunitinib—FLT4—liver—obesity	0.000102	0.000776	CbGeAlD
Sunitinib—YES1—digestive system—obesity	0.000101	0.000774	CbGeAlD
Sunitinib—Hypertension—Bupropion—obesity	0.000101	0.000753	CcSEcCtD
Sunitinib—FLT1—adrenal gland—obesity	0.000101	0.000772	CbGeAlD
Sunitinib—STK10—digestive system—obesity	0.0001	0.000767	CbGeAlD
Sunitinib—Neutropenia—Topiramate—obesity	0.0001	0.000745	CcSEcCtD
Sunitinib—CSNK1E—liver—obesity	0.0001	0.000766	CbGeAlD
Sunitinib—FGFR1—liver—obesity	0.0001	0.000766	CbGeAlD
Sunitinib—RPS6KB1—endocrine gland—obesity	0.0001	0.000765	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Sibutramine—obesity	0.0001	0.000744	CcSEcCtD
Sunitinib—TAOK3—digestive system—obesity	0.0001	0.000764	CbGeAlD
Sunitinib—Dyspepsia—Orlistat—obesity	0.0001	0.000742	CcSEcCtD
Sunitinib—EPHB6—adrenal gland—obesity	9.99e-05	0.000763	CbGeAlD
Sunitinib—Chest pain—Bupropion—obesity	9.99e-05	0.000742	CcSEcCtD
Sunitinib—Myalgia—Bupropion—obesity	9.99e-05	0.000742	CcSEcCtD
Sunitinib—Arthralgia—Bupropion—obesity	9.99e-05	0.000742	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Topiramate—obesity	9.98e-05	0.000741	CcSEcCtD
Sunitinib—FGR—endocrine gland—obesity	9.96e-05	0.00076	CbGeAlD
Sunitinib—RET—endocrine gland—obesity	9.96e-05	0.00076	CbGeAlD
Sunitinib—PDGFRA—digestive system—obesity	9.94e-05	0.000759	CbGeAlD
Sunitinib—Insomnia—Sibutramine—obesity	9.94e-05	0.000738	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	9.92e-05	0.000737	CcSEcCtD
Sunitinib—AXL—endocrine gland—obesity	9.92e-05	0.000757	CbGeAlD
Sunitinib—IRAK4—liver—obesity	9.87e-05	0.000754	CbGeAlD
Sunitinib—Decreased appetite—Orlistat—obesity	9.87e-05	0.000733	CcSEcCtD
Sunitinib—Paraesthesia—Sibutramine—obesity	9.87e-05	0.000733	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Orlistat—obesity	9.8e-05	0.000728	CcSEcCtD
Sunitinib—Dyspnoea—Sibutramine—obesity	9.8e-05	0.000728	CcSEcCtD
Sunitinib—Fatigue—Orlistat—obesity	9.79e-05	0.000727	CcSEcCtD
Sunitinib—Dry mouth—Bupropion—obesity	9.77e-05	0.000726	CcSEcCtD
Sunitinib—Weight decreased—Topiramate—obesity	9.71e-05	0.000721	CcSEcCtD
Sunitinib—Pain—Orlistat—obesity	9.71e-05	0.000721	CcSEcCtD
Sunitinib—Hyperglycaemia—Topiramate—obesity	9.68e-05	0.000719	CcSEcCtD
Sunitinib—Dyspepsia—Sibutramine—obesity	9.67e-05	0.000719	CcSEcCtD
Sunitinib—YES1—adrenal gland—obesity	9.66e-05	0.000737	CbGeAlD
Sunitinib—ULK3—liver—obesity	9.66e-05	0.000737	CbGeAlD
Sunitinib—MAP2K2—liver—obesity	9.66e-05	0.000737	CbGeAlD
Sunitinib—Pneumonia—Topiramate—obesity	9.63e-05	0.000715	CcSEcCtD
Sunitinib—MAP3K2—liver—obesity	9.59e-05	0.000732	CbGeAlD
Sunitinib—Oedema—Bupropion—obesity	9.58e-05	0.000712	CcSEcCtD
Sunitinib—KIT—cardiovascular system—obesity	9.58e-05	0.000731	CbGeAlD
Sunitinib—STK10—adrenal gland—obesity	9.57e-05	0.000731	CbGeAlD
Sunitinib—Infestation—Topiramate—obesity	9.57e-05	0.000711	CcSEcCtD
Sunitinib—Infestation NOS—Topiramate—obesity	9.57e-05	0.000711	CcSEcCtD
Sunitinib—KDR—pituitary gland—obesity	9.57e-05	0.00073	CbGeAlD
Sunitinib—MAP2K5—pituitary gland—obesity	9.57e-05	0.00073	CbGeAlD
Sunitinib—Decreased appetite—Sibutramine—obesity	9.55e-05	0.00071	CcSEcCtD
Sunitinib—Depression—Topiramate—obesity	9.54e-05	0.000709	CcSEcCtD
Sunitinib—TAOK3—adrenal gland—obesity	9.53e-05	0.000728	CbGeAlD
Sunitinib—KDR—adipose tissue—obesity	9.53e-05	0.000727	CbGeAlD
Sunitinib—MAP2K5—adipose tissue—obesity	9.53e-05	0.000727	CbGeAlD
Sunitinib—Infection—Bupropion—obesity	9.52e-05	0.000707	CcSEcCtD
Sunitinib—CYP3A7—endocrine gland—obesity	9.51e-05	0.000726	CbGeAlD
Sunitinib—MAP3K7—liver—obesity	9.5e-05	0.000725	CbGeAlD
Sunitinib—Stevens-Johnson syndrome—Topiramate—obesity	9.49e-05	0.000705	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Sibutramine—obesity	9.49e-05	0.000705	CcSEcCtD
Sunitinib—PDGFRA—adrenal gland—obesity	9.48e-05	0.000723	CbGeAlD
Sunitinib—FGFR2—endocrine gland—obesity	9.46e-05	0.000722	CbGeAlD
Sunitinib—Shock—Bupropion—obesity	9.43e-05	0.0007	CcSEcCtD
Sunitinib—JAK2—endocrine gland—obesity	9.41e-05	0.000718	CbGeAlD
Sunitinib—Renal failure—Topiramate—obesity	9.41e-05	0.000699	CcSEcCtD
Sunitinib—Pain—Sibutramine—obesity	9.4e-05	0.000698	CcSEcCtD
Sunitinib—Constipation—Sibutramine—obesity	9.4e-05	0.000698	CcSEcCtD
Sunitinib—Nervous system disorder—Bupropion—obesity	9.39e-05	0.000698	CcSEcCtD
Sunitinib—TBK1—liver—obesity	9.39e-05	0.000717	CbGeAlD
Sunitinib—Neuropathy peripheral—Topiramate—obesity	9.38e-05	0.000697	CcSEcCtD
Sunitinib—Thrombocytopenia—Bupropion—obesity	9.38e-05	0.000697	CcSEcCtD
Sunitinib—PDGFRB—cardiovascular system—obesity	9.35e-05	0.000714	CbGeAlD
Sunitinib—CSF1R—pituitary gland—obesity	9.34e-05	0.000713	CbGeAlD
Sunitinib—Stomatitis—Topiramate—obesity	9.33e-05	0.000693	CcSEcCtD
Sunitinib—TYK2—liver—obesity	9.33e-05	0.000712	CbGeAlD
Sunitinib—Skin disorder—Bupropion—obesity	9.31e-05	0.000691	CcSEcCtD
Sunitinib—Urinary tract infection—Topiramate—obesity	9.3e-05	0.000691	CcSEcCtD
Sunitinib—CSF1R—adipose tissue—obesity	9.3e-05	0.00071	CbGeAlD
Sunitinib—Gastrointestinal pain—Orlistat—obesity	9.28e-05	0.00069	CcSEcCtD
Sunitinib—FYN—endocrine gland—obesity	9.28e-05	0.000708	CbGeAlD
Sunitinib—IRAK1—liver—obesity	9.2e-05	0.000702	CbGeAlD
Sunitinib—Anorexia—Bupropion—obesity	9.13e-05	0.000678	CcSEcCtD
Sunitinib—MAP4K5—endocrine gland—obesity	9.07e-05	0.000692	CbGeAlD
Sunitinib—MAP3K3—endocrine gland—obesity	9.07e-05	0.000692	CbGeAlD
Sunitinib—RPS6KB1—liver—obesity	9.03e-05	0.000689	CbGeAlD
Sunitinib—Epistaxis—Topiramate—obesity	9.03e-05	0.00067	CcSEcCtD
Sunitinib—Gastrointestinal pain—Sibutramine—obesity	8.99e-05	0.000667	CcSEcCtD
Sunitinib—FGR—liver—obesity	8.98e-05	0.000685	CbGeAlD
Sunitinib—Abdominal pain—Orlistat—obesity	8.98e-05	0.000667	CcSEcCtD
Sunitinib—Body temperature increased—Orlistat—obesity	8.98e-05	0.000667	CcSEcCtD
Sunitinib—KDR—digestive system—obesity	8.97e-05	0.000685	CbGeAlD
Sunitinib—AXL—liver—obesity	8.94e-05	0.000682	CbGeAlD
Sunitinib—FLT1—endocrine gland—obesity	8.77e-05	0.000669	CbGeAlD
Sunitinib—CSF1R—digestive system—obesity	8.75e-05	0.000668	CbGeAlD
Sunitinib—Bradycardia—Topiramate—obesity	8.75e-05	0.00065	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Bupropion—obesity	8.73e-05	0.000648	CcSEcCtD
Sunitinib—Body temperature increased—Sibutramine—obesity	8.69e-05	0.000645	CcSEcCtD
Sunitinib—Abdominal pain—Sibutramine—obesity	8.69e-05	0.000645	CcSEcCtD
Sunitinib—Insomnia—Bupropion—obesity	8.66e-05	0.000644	CcSEcCtD
Sunitinib—Haemoglobin—Topiramate—obesity	8.63e-05	0.000641	CcSEcCtD
Sunitinib—SLK—liver—obesity	8.61e-05	0.000657	CbGeAlD
Sunitinib—Paraesthesia—Bupropion—obesity	8.6e-05	0.000639	CcSEcCtD
Sunitinib—Hepatitis—Topiramate—obesity	8.59e-05	0.000638	CcSEcCtD
Sunitinib—Haemorrhage—Topiramate—obesity	8.59e-05	0.000638	CcSEcCtD
Sunitinib—CYP3A7—liver—obesity	8.57e-05	0.000654	CbGeAlD
Sunitinib—Hypoaesthesia—Topiramate—obesity	8.55e-05	0.000635	CcSEcCtD
Sunitinib—MAP2K5—adrenal gland—obesity	8.55e-05	0.000652	CbGeAlD
Sunitinib—KDR—adrenal gland—obesity	8.55e-05	0.000652	CbGeAlD
Sunitinib—Dyspnoea—Bupropion—obesity	8.54e-05	0.000634	CcSEcCtD
Sunitinib—FGFR2—liver—obesity	8.53e-05	0.000651	CbGeAlD
Sunitinib—Urinary tract disorder—Topiramate—obesity	8.48e-05	0.00063	CcSEcCtD
Sunitinib—JAK2—liver—obesity	8.48e-05	0.000647	CbGeAlD
Sunitinib—KIT—pituitary gland—obesity	8.48e-05	0.000647	CbGeAlD
Sunitinib—Oedema peripheral—Topiramate—obesity	8.46e-05	0.000629	CcSEcCtD
Sunitinib—KIT—adipose tissue—obesity	8.44e-05	0.000645	CbGeAlD
Sunitinib—Connective tissue disorder—Topiramate—obesity	8.44e-05	0.000627	CcSEcCtD
Sunitinib—Dyspepsia—Bupropion—obesity	8.43e-05	0.000626	CcSEcCtD
Sunitinib—Urethral disorder—Topiramate—obesity	8.42e-05	0.000626	CcSEcCtD
Sunitinib—YES1—endocrine gland—obesity	8.38e-05	0.000639	CbGeAlD
Sunitinib—FYN—liver—obesity	8.37e-05	0.000639	CbGeAlD
Sunitinib—Hypersensitivity—Orlistat—obesity	8.37e-05	0.000621	CcSEcCtD
Sunitinib—CSF1R—adrenal gland—obesity	8.34e-05	0.000637	CbGeAlD
Sunitinib—Decreased appetite—Bupropion—obesity	8.33e-05	0.000619	CcSEcCtD
Sunitinib—STK10—endocrine gland—obesity	8.3e-05	0.000633	CbGeAlD
Sunitinib—PDGFRB—pituitary gland—obesity	8.28e-05	0.000632	CbGeAlD
Sunitinib—Gastrointestinal disorder—Bupropion—obesity	8.27e-05	0.000614	CcSEcCtD
Sunitinib—TAOK3—endocrine gland—obesity	8.27e-05	0.000631	CbGeAlD
Sunitinib—Fatigue—Bupropion—obesity	8.26e-05	0.000614	CcSEcCtD
Sunitinib—PDGFRB—adipose tissue—obesity	8.25e-05	0.000629	CbGeAlD
Sunitinib—PDGFRA—endocrine gland—obesity	8.22e-05	0.000627	CbGeAlD
Sunitinib—Constipation—Bupropion—obesity	8.19e-05	0.000609	CcSEcCtD
Sunitinib—Pain—Bupropion—obesity	8.19e-05	0.000609	CcSEcCtD
Sunitinib—MAP4K5—liver—obesity	8.18e-05	0.000624	CbGeAlD
Sunitinib—MAP3K3—liver—obesity	8.18e-05	0.000624	CbGeAlD
Sunitinib—KCNH2—islet of Langerhans—obesity	8.17e-05	0.000624	CbGeAlD
Sunitinib—Asthenia—Orlistat—obesity	8.15e-05	0.000605	CcSEcCtD
Sunitinib—Erythema multiforme—Topiramate—obesity	8.12e-05	0.000603	CcSEcCtD
Sunitinib—Hypersensitivity—Sibutramine—obesity	8.1e-05	0.000601	CcSEcCtD
Sunitinib—Pruritus—Orlistat—obesity	8.03e-05	0.000597	CcSEcCtD
Sunitinib—Eye disorder—Topiramate—obesity	8.03e-05	0.000596	CcSEcCtD
Sunitinib—Flushing—Topiramate—obesity	7.97e-05	0.000592	CcSEcCtD
Sunitinib—Cardiac disorder—Topiramate—obesity	7.97e-05	0.000592	CcSEcCtD
Sunitinib—KIT—digestive system—obesity	7.95e-05	0.000607	CbGeAlD
Sunitinib—FLT1—liver—obesity	7.91e-05	0.000603	CbGeAlD
Sunitinib—Asthenia—Sibutramine—obesity	7.88e-05	0.000586	CcSEcCtD
Sunitinib—Gastrointestinal pain—Bupropion—obesity	7.83e-05	0.000582	CcSEcCtD
Sunitinib—Angiopathy—Topiramate—obesity	7.79e-05	0.000579	CcSEcCtD
Sunitinib—Pruritus—Sibutramine—obesity	7.77e-05	0.000577	CcSEcCtD
Sunitinib—Diarrhoea—Orlistat—obesity	7.77e-05	0.000577	CcSEcCtD
Sunitinib—PDGFRB—digestive system—obesity	7.76e-05	0.000593	CbGeAlD
Sunitinib—Immune system disorder—Topiramate—obesity	7.76e-05	0.000576	CcSEcCtD
Sunitinib—Mediastinal disorder—Topiramate—obesity	7.74e-05	0.000575	CcSEcCtD
Sunitinib—Chills—Topiramate—obesity	7.71e-05	0.000573	CcSEcCtD
Sunitinib—Alopecia—Topiramate—obesity	7.59e-05	0.000564	CcSEcCtD
Sunitinib—KIT—adrenal gland—obesity	7.57e-05	0.000578	CbGeAlD
Sunitinib—Abdominal pain—Bupropion—obesity	7.57e-05	0.000563	CcSEcCtD
Sunitinib—Body temperature increased—Bupropion—obesity	7.57e-05	0.000563	CcSEcCtD
Sunitinib—YES1—liver—obesity	7.55e-05	0.000576	CbGeAlD
Sunitinib—Mental disorder—Topiramate—obesity	7.53e-05	0.000559	CcSEcCtD
Sunitinib—Diarrhoea—Sibutramine—obesity	7.52e-05	0.000558	CcSEcCtD
Sunitinib—Dizziness—Orlistat—obesity	7.51e-05	0.000558	CcSEcCtD
Sunitinib—STK10—liver—obesity	7.48e-05	0.000571	CbGeAlD
Sunitinib—Malnutrition—Topiramate—obesity	7.48e-05	0.000555	CcSEcCtD
Sunitinib—Erythema—Topiramate—obesity	7.48e-05	0.000555	CcSEcCtD
Sunitinib—TAOK3—liver—obesity	7.45e-05	0.000569	CbGeAlD
Sunitinib—KDR—endocrine gland—obesity	7.41e-05	0.000566	CbGeAlD
Sunitinib—MAP2K5—endocrine gland—obesity	7.41e-05	0.000566	CbGeAlD
Sunitinib—PDGFRA—liver—obesity	7.41e-05	0.000565	CbGeAlD
Sunitinib—PDGFRB—adrenal gland—obesity	7.4e-05	0.000565	CbGeAlD
Sunitinib—Flatulence—Topiramate—obesity	7.37e-05	0.000547	CcSEcCtD
Sunitinib—Dysgeusia—Topiramate—obesity	7.32e-05	0.000544	CcSEcCtD
Sunitinib—CYP3A7-CYP3A51P—liver—obesity	7.29e-05	0.000556	CbGeAlD
Sunitinib—Dizziness—Sibutramine—obesity	7.27e-05	0.00054	CcSEcCtD
Sunitinib—Back pain—Topiramate—obesity	7.23e-05	0.000537	CcSEcCtD
Sunitinib—CSF1R—endocrine gland—obesity	7.23e-05	0.000552	CbGeAlD
Sunitinib—Vomiting—Orlistat—obesity	7.22e-05	0.000536	CcSEcCtD
Sunitinib—Muscle spasms—Topiramate—obesity	7.19e-05	0.000534	CcSEcCtD
Sunitinib—Rash—Orlistat—obesity	7.16e-05	0.000532	CcSEcCtD
Sunitinib—Dermatitis—Orlistat—obesity	7.15e-05	0.000531	CcSEcCtD
Sunitinib—Headache—Orlistat—obesity	7.11e-05	0.000528	CcSEcCtD
Sunitinib—Hypersensitivity—Bupropion—obesity	7.06e-05	0.000524	CcSEcCtD
Sunitinib—Vomiting—Sibutramine—obesity	6.99e-05	0.000519	CcSEcCtD
Sunitinib—Rash—Sibutramine—obesity	6.93e-05	0.000515	CcSEcCtD
Sunitinib—Dermatitis—Sibutramine—obesity	6.92e-05	0.000514	CcSEcCtD
Sunitinib—Anaemia—Topiramate—obesity	6.91e-05	0.000513	CcSEcCtD
Sunitinib—Headache—Sibutramine—obesity	6.88e-05	0.000511	CcSEcCtD
Sunitinib—Asthenia—Bupropion—obesity	6.87e-05	0.000511	CcSEcCtD
Sunitinib—Pruritus—Bupropion—obesity	6.78e-05	0.000503	CcSEcCtD
Sunitinib—CYP3A5—islet of Langerhans—obesity	6.75e-05	0.000515	CbGeAlD
Sunitinib—Nausea—Orlistat—obesity	6.74e-05	0.000501	CcSEcCtD
Sunitinib—Leukopenia—Topiramate—obesity	6.69e-05	0.000497	CcSEcCtD
Sunitinib—KDR—liver—obesity	6.68e-05	0.00051	CbGeAlD
Sunitinib—MAP2K5—liver—obesity	6.68e-05	0.00051	CbGeAlD
Sunitinib—KIT—endocrine gland—obesity	6.57e-05	0.000501	CbGeAlD
Sunitinib—ABCC4—adipose tissue—obesity	6.57e-05	0.000501	CbGeAlD
Sunitinib—Diarrhoea—Bupropion—obesity	6.55e-05	0.000487	CcSEcCtD
Sunitinib—Nausea—Sibutramine—obesity	6.53e-05	0.000485	CcSEcCtD
Sunitinib—Cough—Topiramate—obesity	6.53e-05	0.000485	CcSEcCtD
Sunitinib—CSF1R—liver—obesity	6.52e-05	0.000498	CbGeAlD
Sunitinib—Convulsion—Topiramate—obesity	6.48e-05	0.000481	CcSEcCtD
Sunitinib—Hypertension—Topiramate—obesity	6.46e-05	0.00048	CcSEcCtD
Sunitinib—PDGFRB—endocrine gland—obesity	6.42e-05	0.00049	CbGeAlD
Sunitinib—CYP3A5—respiratory system—obesity	6.37e-05	0.000486	CbGeAlD
Sunitinib—Chest pain—Topiramate—obesity	6.37e-05	0.000473	CcSEcCtD
Sunitinib—Myalgia—Topiramate—obesity	6.37e-05	0.000473	CcSEcCtD
Sunitinib—Arthralgia—Topiramate—obesity	6.37e-05	0.000473	CcSEcCtD
Sunitinib—Dizziness—Bupropion—obesity	6.34e-05	0.000471	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	6.32e-05	0.00047	CcSEcCtD
Sunitinib—Dry mouth—Topiramate—obesity	6.23e-05	0.000463	CcSEcCtD
Sunitinib—ABCC4—digestive system—obesity	6.18e-05	0.000472	CbGeAlD
Sunitinib—Oedema—Topiramate—obesity	6.1e-05	0.000453	CcSEcCtD
Sunitinib—Vomiting—Bupropion—obesity	6.09e-05	0.000452	CcSEcCtD
Sunitinib—Infection—Topiramate—obesity	6.06e-05	0.00045	CcSEcCtD
Sunitinib—Rash—Bupropion—obesity	6.04e-05	0.000449	CcSEcCtD
Sunitinib—Dermatitis—Bupropion—obesity	6.03e-05	0.000448	CcSEcCtD
Sunitinib—Shock—Topiramate—obesity	6e-05	0.000446	CcSEcCtD
Sunitinib—Headache—Bupropion—obesity	6e-05	0.000446	CcSEcCtD
Sunitinib—Nervous system disorder—Topiramate—obesity	5.99e-05	0.000445	CcSEcCtD
Sunitinib—ABCC2—digestive system—obesity	5.98e-05	0.000457	CbGeAlD
Sunitinib—Thrombocytopenia—Topiramate—obesity	5.98e-05	0.000444	CcSEcCtD
Sunitinib—Skin disorder—Topiramate—obesity	5.93e-05	0.00044	CcSEcCtD
Sunitinib—KIT—liver—obesity	5.92e-05	0.000452	CbGeAlD
Sunitinib—KCNH2—cardiovascular system—obesity	5.91e-05	0.000451	CbGeAlD
Sunitinib—ABCC4—adrenal gland—obesity	5.89e-05	0.00045	CbGeAlD
Sunitinib—Anorexia—Topiramate—obesity	5.82e-05	0.000432	CcSEcCtD
Sunitinib—PDGFRB—liver—obesity	5.78e-05	0.000441	CbGeAlD
Sunitinib—ABCG2—adrenal cortex—obesity	5.76e-05	0.00044	CbGeAlD
Sunitinib—ABCC2—adrenal gland—obesity	5.7e-05	0.000435	CbGeAlD
Sunitinib—Nausea—Bupropion—obesity	5.69e-05	0.000423	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Topiramate—obesity	5.56e-05	0.000413	CcSEcCtD
Sunitinib—Insomnia—Topiramate—obesity	5.52e-05	0.00041	CcSEcCtD
Sunitinib—Paraesthesia—Topiramate—obesity	5.48e-05	0.000407	CcSEcCtD
Sunitinib—Dyspnoea—Topiramate—obesity	5.44e-05	0.000404	CcSEcCtD
Sunitinib—Dyspepsia—Topiramate—obesity	5.37e-05	0.000399	CcSEcCtD
Sunitinib—Decreased appetite—Topiramate—obesity	5.31e-05	0.000394	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Topiramate—obesity	5.27e-05	0.000391	CcSEcCtD
Sunitinib—Fatigue—Topiramate—obesity	5.26e-05	0.000391	CcSEcCtD
Sunitinib—KCNH2—pituitary gland—obesity	5.23e-05	0.000399	CbGeAlD
Sunitinib—Pain—Topiramate—obesity	5.22e-05	0.000388	CcSEcCtD
Sunitinib—Constipation—Topiramate—obesity	5.22e-05	0.000388	CcSEcCtD
Sunitinib—ABCC4—endocrine gland—obesity	5.11e-05	0.00039	CbGeAlD
Sunitinib—Gastrointestinal pain—Topiramate—obesity	4.99e-05	0.000371	CcSEcCtD
Sunitinib—ABCC2—endocrine gland—obesity	4.94e-05	0.000377	CbGeAlD
Sunitinib—Abdominal pain—Topiramate—obesity	4.82e-05	0.000358	CcSEcCtD
Sunitinib—Body temperature increased—Topiramate—obesity	4.82e-05	0.000358	CcSEcCtD
Sunitinib—KCNH2—adrenal gland—obesity	4.67e-05	0.000357	CbGeAlD
Sunitinib—ABCG2—pituitary gland—obesity	4.65e-05	0.000355	CbGeAlD
Sunitinib—ABCG2—adipose tissue—obesity	4.64e-05	0.000354	CbGeAlD
Sunitinib—ABCC4—liver—obesity	4.61e-05	0.000352	CbGeAlD
Sunitinib—Hypersensitivity—Topiramate—obesity	4.5e-05	0.000334	CcSEcCtD
Sunitinib—ABCC2—liver—obesity	4.46e-05	0.00034	CbGeAlD
Sunitinib—Asthenia—Topiramate—obesity	4.38e-05	0.000325	CcSEcCtD
Sunitinib—Pruritus—Topiramate—obesity	4.32e-05	0.000321	CcSEcCtD
Sunitinib—CYP3A5—adipose tissue—obesity	4.3e-05	0.000328	CbGeAlD
Sunitinib—Diarrhoea—Topiramate—obesity	4.18e-05	0.00031	CcSEcCtD
Sunitinib—ABCG2—adrenal gland—obesity	4.16e-05	0.000317	CbGeAlD
Sunitinib—KCNH2—endocrine gland—obesity	4.05e-05	0.000309	CbGeAlD
Sunitinib—CYP3A5—digestive system—obesity	4.05e-05	0.000309	CbGeAlD
Sunitinib—Dizziness—Topiramate—obesity	4.04e-05	0.0003	CcSEcCtD
Sunitinib—Vomiting—Topiramate—obesity	3.88e-05	0.000288	CcSEcCtD
Sunitinib—Rash—Topiramate—obesity	3.85e-05	0.000286	CcSEcCtD
Sunitinib—Dermatitis—Topiramate—obesity	3.84e-05	0.000286	CcSEcCtD
Sunitinib—Headache—Topiramate—obesity	3.82e-05	0.000284	CcSEcCtD
Sunitinib—Nausea—Topiramate—obesity	3.63e-05	0.000269	CcSEcCtD
Sunitinib—ABCB1—islet of Langerhans—obesity	3.58e-05	0.000274	CbGeAlD
Sunitinib—ABCB1—respiratory system—obesity	3.38e-05	0.000258	CbGeAlD
Sunitinib—CYP3A5—endocrine gland—obesity	3.35e-05	0.000255	CbGeAlD
Sunitinib—ABCG2—liver—obesity	3.25e-05	0.000248	CbGeAlD
Sunitinib—CYP3A4—digestive system—obesity	3.04e-05	0.000232	CbGeAlD
Sunitinib—CYP3A5—liver—obesity	3.02e-05	0.00023	CbGeAlD
Sunitinib—ABCB1—adrenal cortex—obesity	2.84e-05	0.000217	CbGeAlD
Sunitinib—ABCB1—cardiovascular system—obesity	2.59e-05	0.000198	CbGeAlD
Sunitinib—CYP3A4—endocrine gland—obesity	2.51e-05	0.000192	CbGeAlD
Sunitinib—ABCB1—pituitary gland—obesity	2.3e-05	0.000175	CbGeAlD
Sunitinib—ABCB1—adipose tissue—obesity	2.29e-05	0.000174	CbGeAlD
Sunitinib—CYP3A4—liver—obesity	2.26e-05	0.000173	CbGeAlD
Sunitinib—ABCB1—digestive system—obesity	2.15e-05	0.000164	CbGeAlD
Sunitinib—ABCB1—adrenal gland—obesity	2.05e-05	0.000156	CbGeAlD
Sunitinib—ABCB1—endocrine gland—obesity	1.78e-05	0.000136	CbGeAlD
Sunitinib—ABCB1—liver—obesity	1.6e-05	0.000122	CbGeAlD
Sunitinib—JAK2—Disease—TGFB1—obesity	3.56e-07	1.78e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—obesity	3.56e-07	1.78e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—STAT3—obesity	3.55e-07	1.78e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—obesity	3.54e-07	1.77e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—obesity	3.54e-07	1.77e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PRKAR2B—obesity	3.53e-07	1.77e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CB—obesity	3.53e-07	1.77e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—obesity	3.53e-07	1.77e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GNAS—obesity	3.52e-07	1.76e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—obesity	3.52e-07	1.76e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—DCN—obesity	3.51e-07	1.76e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—STAT3—obesity	3.51e-07	1.75e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PIK3CA—obesity	3.5e-07	1.75e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CB—obesity	3.5e-07	1.75e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—obesity	3.5e-07	1.75e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—obesity	3.5e-07	1.75e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—obesity	3.49e-07	1.75e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—obesity	3.48e-07	1.74e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CB—obesity	3.48e-07	1.74e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MTOR—obesity	3.48e-07	1.74e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—obesity	3.47e-07	1.74e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—obesity	3.45e-07	1.73e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—PIK3CA—obesity	3.45e-07	1.73e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOB—obesity	3.45e-07	1.73e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—STAT3—obesity	3.44e-07	1.72e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—STAT3—obesity	3.44e-07	1.72e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—PIK3CA—obesity	3.43e-07	1.72e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—obesity	3.43e-07	1.72e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—obesity	3.43e-07	1.72e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—obesity	3.43e-07	1.72e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—obesity	3.43e-07	1.72e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CPT1A—obesity	3.41e-07	1.71e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MYC—obesity	3.4e-07	1.7e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—obesity	3.39e-07	1.7e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PIK3CA—obesity	3.39e-07	1.7e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—obesity	3.38e-07	1.69e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NAMPT—obesity	3.35e-07	1.68e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—obesity	3.33e-07	1.67e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LIPC—obesity	3.33e-07	1.66e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCK—obesity	3.33e-07	1.66e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PIK3CA—obesity	3.31e-07	1.66e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOC3—obesity	3.31e-07	1.65e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—obesity	3.3e-07	1.65e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CG—obesity	3.3e-07	1.65e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—obesity	3.3e-07	1.65e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MYC—obesity	3.3e-07	1.65e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—LPL—obesity	3.29e-07	1.65e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK8—obesity	3.29e-07	1.65e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—obesity	3.29e-07	1.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—PIK3CA—obesity	3.28e-07	1.64e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—obesity	3.28e-07	1.64e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—obesity	3.28e-07	1.64e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—STAT3—obesity	3.27e-07	1.64e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—obesity	3.27e-07	1.63e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—obesity	3.26e-07	1.63e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—STAT3—obesity	3.26e-07	1.63e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MYC—obesity	3.26e-07	1.63e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—obesity	3.26e-07	1.63e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—obesity	3.25e-07	1.63e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—obesity	3.25e-07	1.63e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—obesity	3.25e-07	1.63e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—obesity	3.25e-07	1.63e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—obesity	3.23e-07	1.62e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—obesity	3.23e-07	1.61e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GPX1—obesity	3.21e-07	1.61e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK8—obesity	3.21e-07	1.61e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CETP—obesity	3.21e-07	1.61e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—obesity	3.2e-07	1.6e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—obesity	3.2e-07	1.6e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—obesity	3.19e-07	1.6e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—obesity	3.19e-07	1.6e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PIK3CA—obesity	3.19e-07	1.6e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARG—obesity	3.19e-07	1.6e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—obesity	3.18e-07	1.59e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—obesity	3.18e-07	1.59e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—obesity	3.18e-07	1.59e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—obesity	3.18e-07	1.59e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SDC1—obesity	3.17e-07	1.59e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—obesity	3.17e-07	1.59e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PIK3CA—obesity	3.17e-07	1.59e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—obesity	3.17e-07	1.59e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—obesity	3.17e-07	1.58e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—obesity	3.16e-07	1.58e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—obesity	3.14e-07	1.57e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CD36—obesity	3.13e-07	1.57e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—INS—obesity	3.13e-07	1.56e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKR1C3—obesity	3.12e-07	1.56e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—obesity	3.1e-07	1.55e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK8—obesity	3.1e-07	1.55e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK8—obesity	3.08e-07	1.54e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SCARB1—obesity	3.07e-07	1.54e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—obesity	3.07e-07	1.54e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—obesity	3.06e-07	1.53e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—obesity	3.05e-07	1.53e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—obesity	3.04e-07	1.52e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PIK3CA—obesity	3.04e-07	1.52e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—obesity	3.04e-07	1.52e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PIK3CA—obesity	3.03e-07	1.52e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—obesity	3.03e-07	1.52e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—obesity	3.03e-07	1.52e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—obesity	3.03e-07	1.52e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—obesity	3.03e-07	1.51e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—obesity	3.02e-07	1.51e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—STAT3—obesity	3.01e-07	1.51e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—obesity	3.01e-07	1.5e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—obesity	3e-07	1.5e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—obesity	3e-07	1.5e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—obesity	3e-07	1.5e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SREBF1—obesity	2.98e-07	1.49e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—obesity	2.97e-07	1.48e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK8—obesity	2.94e-07	1.47e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—STAT3—obesity	2.94e-07	1.47e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—obesity	2.94e-07	1.47e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—obesity	2.94e-07	1.47e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—obesity	2.93e-07	1.47e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—obesity	2.93e-07	1.47e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—obesity	2.93e-07	1.46e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARA—obesity	2.91e-07	1.46e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—obesity	2.91e-07	1.45e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CD—obesity	2.9e-07	1.45e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GOT2—obesity	2.9e-07	1.45e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PIK3CA—obesity	2.88e-07	1.44e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—obesity	2.87e-07	1.43e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—obesity	2.86e-07	1.43e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—FASN—obesity	2.84e-07	1.42e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—STAT3—obesity	2.83e-07	1.42e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—BCHE—obesity	2.83e-07	1.42e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—obesity	2.82e-07	1.41e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—obesity	2.82e-07	1.41e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AGT—obesity	2.82e-07	1.41e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—STAT3—obesity	2.81e-07	1.41e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—obesity	2.81e-07	1.41e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—obesity	2.81e-07	1.4e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PIK3CA—obesity	2.8e-07	1.4e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—obesity	2.8e-07	1.4e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—obesity	2.79e-07	1.4e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—obesity	2.77e-07	1.39e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PIK3CA—obesity	2.76e-07	1.38e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOE—obesity	2.76e-07	1.38e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—obesity	2.74e-07	1.37e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3R1—obesity	2.74e-07	1.37e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CAV1—obesity	2.74e-07	1.37e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOA1—obesity	2.73e-07	1.37e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2E1—obesity	2.73e-07	1.37e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—obesity	2.73e-07	1.37e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—obesity	2.72e-07	1.36e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PIK3CA—obesity	2.72e-07	1.36e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PIK3CA—obesity	2.72e-07	1.36e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—obesity	2.7e-07	1.35e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NQO1—obesity	2.7e-07	1.35e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—obesity	2.69e-07	1.35e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—STAT3—obesity	2.69e-07	1.35e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—obesity	2.68e-07	1.34e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—obesity	2.68e-07	1.34e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—obesity	2.63e-07	1.32e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—obesity	2.62e-07	1.31e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—obesity	2.62e-07	1.31e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—obesity	2.61e-07	1.31e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—obesity	2.6e-07	1.3e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—obesity	2.59e-07	1.3e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC2A4—obesity	2.59e-07	1.29e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCG—obesity	2.59e-07	1.29e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PIK3CA—obesity	2.58e-07	1.29e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PIK3CA—obesity	2.57e-07	1.29e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—obesity	2.55e-07	1.28e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYCS—obesity	2.55e-07	1.28e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CB—obesity	2.53e-07	1.27e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—obesity	2.51e-07	1.25e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GGT1—obesity	2.5e-07	1.25e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GOT1—obesity	2.5e-07	1.25e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—obesity	2.5e-07	1.25e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—obesity	2.49e-07	1.25e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CG—obesity	2.49e-07	1.25e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—obesity	2.48e-07	1.24e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—obesity	2.48e-07	1.24e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—obesity	2.48e-07	1.24e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NCOA1—obesity	2.47e-07	1.23e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—obesity	2.45e-07	1.23e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP19A1—obesity	2.43e-07	1.22e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—STK11—obesity	2.43e-07	1.22e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARG—obesity	2.41e-07	1.2e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—obesity	2.4e-07	1.2e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—obesity	2.4e-07	1.2e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CA—obesity	2.37e-07	1.19e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—obesity	2.37e-07	1.19e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—INS—obesity	2.36e-07	1.18e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—obesity	2.36e-07	1.18e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CA—obesity	2.32e-07	1.16e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—obesity	2.29e-07	1.14e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—obesity	2.28e-07	1.14e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—obesity	2.28e-07	1.14e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—COMT—obesity	2.26e-07	1.13e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—obesity	2.26e-07	1.13e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CA—obesity	2.23e-07	1.12e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GNB3—obesity	2.23e-07	1.12e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARGC1A—obesity	2.23e-07	1.12e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CA—obesity	2.22e-07	1.11e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMOX1—obesity	2.22e-07	1.11e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—obesity	2.22e-07	1.11e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—obesity	2.22e-07	1.11e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CD—obesity	2.19e-07	1.1e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GNAS—obesity	2.17e-07	1.09e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—obesity	2.16e-07	1.08e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CA—obesity	2.15e-07	1.08e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CA—obesity	2.13e-07	1.07e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOB—obesity	2.13e-07	1.06e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CA—obesity	2.12e-07	1.06e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—obesity	2.11e-07	1.05e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—obesity	2.1e-07	1.05e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—obesity	2.1e-07	1.05e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3R1—obesity	2.07e-07	1.04e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—obesity	2.07e-07	1.04e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—obesity	2.05e-07	1.03e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LPL—obesity	2.03e-07	1.02e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GPX1—obesity	1.98e-07	9.91e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—obesity	1.98e-07	9.89e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—obesity	1.97e-07	9.84e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—obesity	1.94e-07	9.7e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CD36—obesity	1.93e-07	9.65e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CB—obesity	1.91e-07	9.56e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—obesity	1.89e-07	9.47e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—obesity	1.89e-07	9.47e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—obesity	1.88e-07	9.4e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—obesity	1.83e-07	9.15e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—obesity	1.82e-07	9.13e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—obesity	1.81e-07	9.08e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARA—obesity	1.79e-07	8.97e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—obesity	1.76e-07	8.8e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—obesity	1.74e-07	8.73e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AGT—obesity	1.74e-07	8.69e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—obesity	1.73e-07	8.67e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOE—obesity	1.7e-07	8.51e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAV1—obesity	1.69e-07	8.44e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOA1—obesity	1.68e-07	8.42e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CA—obesity	1.54e-07	7.72e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CG—obesity	1.54e-07	7.68e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARG—obesity	1.48e-07	7.42e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—obesity	1.46e-07	7.31e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—INS—obesity	1.45e-07	7.27e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CD—obesity	1.35e-07	6.76e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—obesity	1.33e-07	6.67e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3R1—obesity	1.27e-07	6.38e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—obesity	1.27e-07	6.38e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—obesity	1.26e-07	6.31e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CB—obesity	1.18e-07	5.89e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—obesity	1.17e-07	5.83e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CA—obesity	1.16e-07	5.83e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—obesity	9.51e-08	4.76e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CA—obesity	7.17e-08	3.59e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—obesity	5.86e-08	2.93e-07	CbGpPWpGaD
